CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Noncontrolling Interest, Increase from Business Combination
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Noncontrolling Interest, Increase from Business Combination of $475.00 thousand for the 3-month period ending 2014-03-29, per its 10-Q filed 2014-04-30.
Discontinued › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination · last filed 2014-04-30
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, increase from business combination for the quarter ending 2014-03-29 was $475.00K, a 94.70% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, increase from business combination for the quarter ending 2013-09-28 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, increase from business combination for the quarter ending 2013-06-29 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. noncontrolling interest, increase from business combination for the quarter ending 2013-03-30 was $8.96M.
| Period end | Noncontrolling Interest, Increase from Business Combination 3 month | Noncontrolling Interest, Increase from Business Combination 6 month | Noncontrolling Interest, Increase from Business Combination 9 month |
|---|---|---|---|
| 2014-03-29 | $475.00K 10-Q · filed 2014-04-30 | ||
| 2013-09-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $0.00 derived: sum of 2 quarters · filed 2013-10-30 | $8.96M 10-Q · filed 2013-10-30 |
| 2013-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $8.96M 10-Q · filed 2013-07-31 | |
| 2013-03-30 | $8.96M 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |